Accelerating SARS-CoV-2 genomic surveillance in a routine clinical setting with nanopore sequencing

CONCLUSIONS: Parallel integration of Illumina and nanopore sequencing strategies is a suitable solution to ensure both high-throughput and rapid response to cope with accelerating the surveillance demands of SARS-CoV-2 while also maintaining accuracy.PMID:38290400 | DOI:10.1016/j.ijmm.2024.151599

Source: International Journal of Medical Microbiology - January 30, 2024 Category: Microbiology Authors: Sergio Buenestado-Serrano Marta Herranz Álvaro Otero-Sobrino Andrea Molero-Salinas Cristina Rodr íguez-Grande Amadeo Sanz-P érez Mar ía José Durán Galván Pilar Catal án Roberto Alonso Patricia Mu ñoz Laura P érez-Lago Dar ío García de Viedma G Source Type: research